Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Research is being conducted on the use of psilocybin for treatment-resistant depression in patients taking certain medications, including SSRIs. Some studies suggest that psilocybin may be effective in treating depression, with effects lasting up to a year for some patients. However, there are also reports of potential risks and complications associated with psilocybin use, particularly when combined with other medications.
Full coverage
12345678